Antiretroviral News and Research

RSS

AIDS 2012 plenary speakers call for expanded efforts to provide HIV treatment, prevention to women, children

AIDS experts speaking at the XIX International AIDS Conference (AIDS 2012) on Wednesday called for an expansion of HIV care and treatment to all women instead of focusing only on those who are pregnant, the Associated Press reports.

27 Jul 2012

A key question at this week's AIDS Conference: Who will pay the worldwide costs of treatment?

A roundup of news from the International AIDS Conference taking place this week in Washington.

27 Jul 2012

Lymphoma drug dislodges hidden virus in HIV patients

Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment for HIV.

27 Jul 2012

HIV drug resistance: an interview with Dr. Silvia Bertagnolio

Sexual intercourse is the major mode of HIV transmission. HIV may also be transmitted through sharing of needles or contaminated blood products (although this is rare).

27 Jul 2012

HPTN study results show additional benefits of early ART in HIV clinical outcomes

Study results released today by the HIV Prevention Trials Network (HPTN) show additional benefits of early antiretroviral therapy (ART) in HIV clinical outcomes.

27 Jul 2012

First Edition: July 26, 2012

Today's headlines include coverage of findings from a new study that indicate Medicaid may help people live longer.

26 Jul 2012

Recent release: Blogs discuss advancements in HIV preventative, therapeutic R&D

In this post in the Center for Global Health Policy's "Science Speaks" blog, IAVI President and CEO Margaret McGlynn, AVAC Executive Director Mitchell Warren and UNAIDS Executive Director Michel Sidibe highlight the release of a report from the HIV Vaccine & Microbicides Resource Tracking Working Group.

26 Jul 2012

Recent release: More effort needed to reach universal access to ART by 2015, MSF/UNAIDS report says

"Much still needs to be done to get treatment to those who need it and to meet the UNAIDS-endorsed goal to achieve universal access by 2015, according to a new survey examining 25 HIV indicators assessing strategies, tools and policies to get the best HIV treatment to more people, sooner," the Center for Global Health Policy's "Science Speaks" blog reports.

26 Jul 2012

Survey offers solutions to meet the needs of young people with HIV

Very few children are born with HIV in Thailand today. During the 1990s, the Thai government implemented a vast prevention programme in order to control the epidemic that was rife in the North of the country. The reduction of mother-to-child transmission was one of the major successes resulting from these measures. However, before this programme was established, numerous infants were born with the infection.

25 Jul 2012

Community health campaigns reduce incidence of HIV virus levels in rural Uganda

Population-wide levels of HIV virus dropped substantially between 2011 and May 2012 in a rural part of southwestern Uganda, the site of two community health campaigns led by doctors at the University of California, San Francisco (UCSF), San Francisco General Hospital and Trauma Center (SFGH) and Makerere University in Kampala, Uganda.

25 Jul 2012

Drug resistance increasing in parts of Africa, report shows

"Resistance to AIDS drugs, a problem that has been widely feared over the last decade, is growing in parts of Africa but should not hamper the life-saving drug rollout, researchers reported on Monday" in a study published in the Lancet, Agence France-Presse reports.

25 Jul 2012

Dapivirine Phase III trial now underway in Africa to treat HIV in women

A large clinical trial testing the long-term safety and effectiveness of a new approach for preventing HIV in women - a vaginal ring used once a month - is now underway in Africa, researchers announced today at the XIX International AIDS Conference (AIDS 2012).

25 Jul 2012

Views on AIDS: The benefits of male circumcision; A more optimistic battle; The need to focus on high-impact prevention strategies

A selection of editorials and op-eds from around the country that focus on the campaign to eradicate HIV.

25 Jul 2012

Recent release: Global Fund results show 3.6M people on HIV treatment under fund-supported programs

In a round-up of events from the XIX International AIDS Conference on the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Trevor DeWitt, new media communications officer for the foundation, notes that the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday released results "showing broad gains in the number of people receiving HIV treatment."

24 Jul 2012

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Today, U.S. Food and Drug Administration (FDA) Commissioner Margaret A. Hamburg announced the agency has approved or tentatively approved a total of 152 antiretroviral drugs in association with the President's Emergency Plan for AIDS Relief (PEPFAR) to treat those infected with HIV/AIDS in countries that lack the tools needed to fight the AIDS epidemic.

24 Jul 2012

Novel combination drug regimen could be more effective than existing treatments for TB

A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet.

24 Jul 2012

International Antiviral Society-USA calls for treatment for all who test HIV-positive

"An international group of scientists on Sunday called for all adults who test positive for HIV to be treated with antiretroviral drugs right away rather than waiting for their immune systems to weaken," Agence France-Presse reports.

24 Jul 2012

TB combination drug trials progress

A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients’ TB bacteria within two weeks and could be more effective than existing treatments, according to a study published today in the Lancet. These results add to a growing body of evidence that the new regimen could reduce treatment by more than a year for some patients.

24 Jul 2012

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

The story of the AIDS pandemic has been grim for so long that optimism seems hardly possible. But as the 19th International AIDS conference opens in Washington on Sunday, there is hope for control of a disease that has killed nearly 35 million people over three decades and 1.7 million in the past year.

23 Jul 2012

HIV drug resistance rates rising in some parts of Africa

New research published Online First in The Lancet suggests that drug-resistant HIV has been increasing in parts of Sub-Saharan Africa since the roll-out of antiretroviral therapy (ART) nearly a decade ago.

23 Jul 2012

Antiretroviral News and Research

AIDS 2012 plenary speakers call for expanded efforts to provide HIV treatment, prevention to women, children

A key question at this week's AIDS Conference: Who will pay the worldwide costs of treatment?

Lymphoma drug dislodges hidden virus in HIV patients

HIV drug resistance: an interview with Dr. Silvia Bertagnolio

HPTN study results show additional benefits of early ART in HIV clinical outcomes

First Edition: July 26, 2012

Recent release: Blogs discuss advancements in HIV preventative, therapeutic R&D

Recent release: More effort needed to reach universal access to ART by 2015, MSF/UNAIDS report says

Survey offers solutions to meet the needs of young people with HIV

Community health campaigns reduce incidence of HIV virus levels in rural Uganda

Drug resistance increasing in parts of Africa, report shows

Dapivirine Phase III trial now underway in Africa to treat HIV in women

Views on AIDS: The benefits of male circumcision; A more optimistic battle; The need to focus on high-impact prevention strategies

Recent release: Global Fund results show 3.6M people on HIV treatment under fund-supported programs

FDA approves 152 antiretroviral drugs in association with PEPFAR to treat HIV/AIDS

Novel combination drug regimen could be more effective than existing treatments for TB

International Antiviral Society-USA calls for treatment for all who test HIV-positive

TB combination drug trials progress

Views on AIDS: Despite advances, still no cure, no vaccine, and indifference grows

HIV drug resistance rates rising in some parts of Africa

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News